Dutasteride INN 0.5mg Capsule
It is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to; 1. Improve symptoms, 2. Reduce the risk of acute urinary retention, 3. Reduce the risk of the need for BPH-related surgery.
Dutasteride INN 0.5mg Capsule
It is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to; 1. Improve symptoms, 2. Reduce the risk of acute urinary retention, 3. Reduce the risk of the need for BPH-related surgery.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.